Search Within

MSK Grad Students

  1. "Dermatology"
Formats
  1. Meeting Abstract (20)
  2. Journal Article (14)
  3. Correspondence (3)
  4. Review (3)
  5. Editorial (2)
  6. Miscellaneous (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (45)
  2. Dermatology (45)
  3. Dermatology Service (45)
  4. Division of Subspecialty Medicine (45)
  5. CTCR Scholars (38)
  6. Master of Science in Clinical and Translational Cancer Research (38)

More Groups

People
  1. Edmund Bartlett (19)
  2. Michael Marchetti (19)
  3. Alina Markova (16)
  4. Doris Ponce (15)
  5. Stephen Dusza (13)
  6. Daniel Coit (9)

More People

Years
  1. 2024 (5)
  2. 2023 (7)
  3. 2022 (11)
  4. 2021 (6)
  5. 2020 (7)
  6. 2019 (5)

More Years

Publications
  1. Journal of the American Academy of Dermatology (8)
  2. Blood (6)
  3. JAMA Dermatology (5)
  4. Transplantation and Cellular Therapy (5)
  5. Annals of Surgical Oncology (4)
  6. Journal of the American College of Surgeons (4)

More Publications

Publishers
  1. Elsevier Inc. (8)
  2. Mosby Elsevier (8)
  3. American Society of Hematology (6)
  4. American Medical Association (5)
  5. Elsevier Science, Inc. (5)
  6. Springer (5)

More Publishers

Results (45)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early detection and prognostic assessment of cutaneous melanoma: Consensus on optimal practice and the role of gene expression profile testing
    Review

    Kashani-Sabet, M.; Leachman, S. A.; Stein, J. A.; Arbiser, J. L.; Berry, E. G.; Celebi, J. T.; Curiel-Lewandrowski, C.; Ferris, L. K.; Grant-Kels, J. M.; Grossman, D.; more...
    JAMA Dermatology (2023)

    Fulltext@MSK | Save
  • Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB/C melanoma: A population-based analysis
    Journal Article

    Sharon, C. E.; Straker, R. J. 3rd; Gimotty, P. A.; Chu, E. Y.; Mitchell, T. C.; Miura, J. T.; Marchetti, M. A.; Bartlett, E. K.; Karakousis, G. C.
    Journal of the American Academy of Dermatology (2023)

    Fulltext@MSK | Save
  • Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert tumor microenvironment
    Meeting Abstract

    Yan, J.; Chen, Y.; Patel, A. J.; Lee, C. J.; Warda, S.; Nixon, B. G.; Wong, E. W. P.; Miranda-Román, M. A.; Yang, N.; Wang, Y.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Clinically significant risk thresholds in the management of primary cutaneous melanoma: A survey of melanoma experts
    Miscellaneous

    Bartlett, E. K.; Grossman, D.; Swetter, S. M.; Leachman, S. A.; Curiel-Lewandrowski, C.; Dusza, S. W.; Gershenwald, J. E.; Kirkwood, J. M.; Tin, A. L.; Vickers, A. J.; more...
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses
    Journal Article

    Yan, J.; Chen, Y.; Patel, A. J.; Warda, S.; Lee, C. J.; Nixon, B. G.; Wong, E. W. P.; Miranda-Román, M. A.; Yang, N.; Wang, Y.; more...
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • Clinically significant risk thresholds in the management of primary cutaneous melanoma: A survey of melanoma experts
    Journal Article

    Bartlett, E. K.; Grossman, D.; Swetter, S. M.; Leachman, S. A.; Curiel-Lewandrowski, C.; Dusza, S. W.; Gershenwald, J. E.; Kirkwood, J. M.; Tin, A. L.; Vickers, A. J.; more...
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • ASO Author Reflections: Why treatment risk thresholds are needed for patients with melanoma
    Editorial

    Bartlett, E. K.; Marchetti, M. A.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Peri-transplant vitamin and micronutrient status in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Rodich, L.; Adintori, P. A.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Gossman, Z.; Shike, M.; Barker, J. N.; Jakubowski, A. A.; Kernan, N. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Interim results of a pilot, prospective, randomized, double-blinded, vehicle-controlled trial on safety and efficacy of a topical inhibitor of Janus kinase 1/2 (ruxolitinib INCB018424 phosphate 1.5% cream) for non-sclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease
    Meeting Abstract

    Markova, A.; Prockop, S. E.; Dusza, S.; Pan, A.; Chowdhury, A.; Lacouture, M. E.; Perales, M. A.; Ponce, D. M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Noninvasive genomic characterization of patients with nonsclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease identified a novel gene signature in responders to ruxolitinib cream
    Meeting Abstract

    Markova, A.; Whitaker, J. W.; Ai, R.; Pan, A.; Dusza, S.; Lacouture, M. E.; Chowdhury, A.; Perales, M. A.; Prockop, S. E.; Ponce, D. M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save